Study identifier:NIS-CRS-DUM-2010/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
An epidemiological study to evaluate standard daily practice in managing patients with arterial hypertension and to evaluate patients’ quality of life
hypertension
-
No
-
All
300
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
1 Subject population with essential arterial hypertension currently receiving treatment with a calcium antagonist | - |